Primary cutaneous melanoma. Identification of prognostic groups and estimation of individual prognosis for 5093 patients

Cancer

Volumn 75, Issue 10, 1995, Pages 2484-2491

  Garbe, Claus ^a   Büttner, Petra ^a   Bertz, Jochen ^b   Burg, Günter ^c   d'Hoedt, Barbara ^d   Drepper, Hubert ^e   Guggenmoos‐Holzmann, Irene ^a   Lechner, Walter ^c   Lippold, Andrea ^e   Orfanos, Constantin E ^a   Peters, Almut ^e   Rassner, Gernot ^d   Stadler, Rudolf ^a   Stroebel, Waltraud ^d  

^a University Medical Center Steglitz   (Germany)

^b Federal Health Office   (Germany)

^c University Department of Dermatology ^*  (Germany)

^d UNIVERSITY OF TÜBINGEN   (Germany)

^e Fachklinik Hornheide   (Germany)

Author keywords

individual prognosis; multivariate analysis; primary cutaneous melanoma; prognostic groups

Indexed keywords

ADULT; AGE; ARTICLE; CANCER LOCALIZATION; CANCER SURVIVAL; FEMALE; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL; PROGNOSIS; SEX DIFFERENCE; STATISTICAL ANALYSIS; TUMOR VOLUME;

AGE FACTORS; COMPARATIVE STUDY; FEMALE; FOLLOW-UP STUDIES; GERMANY; HUMAN; LONGITUDINAL STUDIES; MALE; MELANOMA; MIDDLE AGE; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROBABILITY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REGRESSION ANALYSIS; SEX FACTORS; SKIN NEOPLASMS; SUPPORT, NON-U.S. GOV'T; SURVIVAL RATE;

EID: 0029065312     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19950515)75:10<2484::AID-CNCR2820751014>3.0.CO;2-U     Document Type: Article

References (44)

1. Epidemiology of malilgnant melanoma in Central Europe: risk factors and prognostic predictors
2. Classification and staging
3. Thickness, cross‐sectional areas and depth of invasion in the prognosis of cutaneous melanoma
4. A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods
5. Tumor thickness as a guide to surgical management of clinical Stage I melanoma patients
6. Prognostic significance of the histological features of malignant melanoma
7. The natural break points for primary‐tumor thickness in clinical Stage I melanoma
8. Survival with primary cutaneous malignant melanoma, evaluated from 2012 cases
9. Therapeutic and clinicopathological factors in survival of 1, 469 patients with primary cutaneous malignant melanoma in clinical Stage I
10. Cutaneous malignant melanoma (Arizona Cancer Center Experience): I. the natural history and prognostic factors influencing survival in patients with Stage I disease
11. Tumor thickness and prognosis in clinical Stage I malignant melanoma
12. An analysis of prognostic factors in 8500 patients with cutaneous melanoma
13. Multivariate analysis of the relationship between survival and the microstage of primary melanoma by Clark level and Breslow thickness
14. The histogenesis and biologic behavior of primary human malignant melanoma of the skin
15. Prognostic factors for patients with clinical Stage I melanoma of intermediate thickness (1.51‐3.99 mm): a conceptual model for tumor growth and metastasis
16. Influence of level and depth on recurrence rate in thin melanomas
17. Prognosis of Stage I melanoma of the skin
18. A prognostic model for clinical Stage I melanoma of the upper extremity: the importance of anatomic subsites in predicting recurrent disease
19. A multivariate analysis of prognostic factors for melanoma patients with lesions ≥ 3.65 mm in thickness: the importance of revealing alternative Cox models
20. The prognostic significance of ulceration of cutaneous melanoma
21. Prognostic index in malignant melanoma
22. Low‐ and high‐risk malignant melanoma: I. evaluation of clinical and histological prognosticators in 585 cases
23. Low‐ and high‐risk malignant melanoma: II. multivariate analysis for a prognostic classification
24. Eight year survival in malignant melanoma related to sex and to tumor location
25. Prognostic factors for melanoma patients with lesions 0.76‐1.69 mm in thickness: an appraisal of ‘thin’ level IV lesions
26. Effect of anatomical location on prognosis in patients with clinical Stage I melanoma
27. Influence of gender on survival in patients with Stage I malignant melanoma
28. Cutaneous malignant melanoma of the head and neck
29. A retrospective study of 669 cases of primary cutaneous malignant melanoma in clinical Stage I
30. Histologic features of tumors and female superiority in survival from malignant melanoma
31. Sex related survival differences in instances of melanoma
32. Prognosis of clinical Stage I melanoma patients with positive elective regional node dissection
33. Non‐parametric estimation from incomplete observations
34. Evaluation of survival data and two new rank order statistics arising in its consideration
35. Regression models and life tables (with discussion)
36. Prognostic factors for Stage I melanoma of the skin: a review
37. Influence of anatomic location on prognosis of malignant melanoma: attempt to verify the BANS model
38. Effect of BANS location on the prognosis of clinical Stage I melanoma: new data and meta‐analysis
39. Prognostic factors and risk groups: some results given by using an algorithm suitable for censored survival data